{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:20:10Z","timestamp":1794961210325,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Basic Research Project","award":["2012CB518100"],"award-info":[{"award-number":["2012CB518100"]}]},{"name":"National Natural Scientific grants","award":["81271381"],"award-info":[{"award-number":["81271381"]}]},{"name":"Program for Shanghai Outstanding Medical Academic Leader","award":["2014529"],"award-info":[{"award-number":["2014529"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Glial fibrillary acidic protein (GFAP) may serve as a serum marker of traumatic brain injury (TBI) that can be used to monitor biochemical changes in patients and gauge the response to treatment. However, the temporal profile of serum GFAP in the acute period of brain injury and the associated utility for outcome prediction has not been elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective longitudinal cohort study of consecutive severe TBI patients in a local tertiary neurotrauma center in Shanghai, China, between March 2011 and September 2014. All patients were monitored and managed with a standardized protocol with inclusion of hypothermia and other intensive care treatments. Serum specimens were collected on admission and then daily for the first 5\u00a0days. GFAP levels were measured using enzyme-linked immunosorbent assay techniques. Patient outcome was assessed at 6\u00a0months post injury with the Glasgow Outcome Scale and further grouped into death versus survival and unfavorable versus favorable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 67 patients were enrolled in the study. The mean time from injury to admission was 2.6\u00a0hours, and the median admission Glasgow Coma Scale score was 6. Compared with healthy subjects, patients with severe TBI had increased GFAP levels on admission and over the subsequent 5\u00a0days post injury. Serum GFAP levels showed a gradual reduction from admission to day 3, and then rebounded on day 4 when hypothermia was discontinued with slow rewarming. GFAP levels were significantly higher in patients who died or had an unfavorable outcome across all time points than in those who were alive or had a favorable outcome. Results of receiver operating characteristic curve analysis indicated that serum GFAP at each time point could predict neurological outcome at 6\u00a0months. The areas under the curve for GFAP on admission were 0.761 for death and 0.823 for unfavorable outcome, which were higher than those for clinical variables such as age, Glasgow Coma Scale score, and pupil reactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum GFAP levels on admission and during the first 5\u00a0days of injury were increased in patients with severe TBI and were predictive of neurological outcome at 6\u00a0months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-015-1081-8","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T09:48:26Z","timestamp":1444297706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Jin","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"1081_CR1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0140-6736(12)60864-2","volume":"380","author":"JV Rosenfeld","year":"2012","unstructured":"Rosenfeld JV, Maas AI, Bragge P, Morganti-Kossmann MC, Manley GT, Gruen RL. Early management of severe traumatic brain injury. Lancet. 2012;380:1088\u201398.","journal-title":"Lancet"},{"key":"1081_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.66.1.20","volume":"66","author":"DF Signorini","year":"1999","unstructured":"Signorini DF, Andrews PJ, Jones PA, Wardlaw JM, Miller JD. Predicting survival using simple clinical variables: a case study in traumatic brain injury. J Neurol Neurosurg Psychiatry. 1999;66:20\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1081_CR3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(14)70120-6","volume":"13","author":"G Teasdale","year":"2014","unstructured":"Teasdale G, Maas A, Lecky F, Manley G, Stocchetti N, Murray G. The Glasgow Coma Scale at 40\u00a0years: standing the test of time. Lancet Neurol. 2014;13:844\u201354.","journal-title":"Lancet Neurol"},{"key":"1081_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12028-012-9795-9","volume":"19","author":"B Jacobs","year":"2013","unstructured":"Jacobs B, Beems T, van der Vliet TM, van Vugt AB, Hoedemaekers C, Horn J, et al. Outcome prediction in moderate and severe traumatic brain injury: a focus on computed tomography variables. Neurocrit Care. 2013;19:79\u201389.","journal-title":"Neurocrit Care"},{"key":"1081_CR5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2741\/4335","volume":"20","author":"L Gao","year":"2015","unstructured":"Gao L, Wu X. Prediction of clinical outcome in severe traumatic brain injury. Front Biosci (Landmark Ed). 2015;20:763\u201371.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1081_CR6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/cc13841","volume":"18","author":"S Mrozek","year":"2014","unstructured":"Mrozek S, Dumurgier J, Citerio G, Mebazaa A, Geeraerts T. Biomarkers and acute brain injuries: interest and limits. Crit Care. 2014;18:220.","journal-title":"Crit Care"},{"key":"1081_CR7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1227\/NEU.0b013e318214a81f","volume":"68","author":"AE B\u00f6hmer","year":"2011","unstructured":"B\u00f6hmer AE, Oses JP, Schmidt AP, Per\u00f3n CS, Krebs CL, Oppitz PP, et al. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery. 2011;68:1624\u201330.","journal-title":"Neurosurgery"},{"key":"1081_CR8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KKW. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364\u201374.","journal-title":"Trends Neurosci"},{"key":"1081_CR9","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/WNL.0b013e3181fd62d2","volume":"75","author":"PE Vos","year":"2010","unstructured":"Vos PE, Jacobs B, Andriessen TM, Lamers KJ, Borm GF, Beems T, et al. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology. 2010;75:1786\u201393.","journal-title":"Neurology"},{"key":"1081_CR10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5595","volume":"346","author":"H Hemingway","year":"2013","unstructured":"Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, et al. Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ. 2013;346, e5595.","journal-title":"BMJ"},{"key":"1081_CR11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.clinbiochem.2014.01.028","volume":"47","author":"FG Strathmann","year":"2014","unstructured":"Strathmann FG, Schulte S, Goerl K, Petron DJ. Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives. Clin Biochem. 2014;47:876\u201388.","journal-title":"Clin Biochem"},{"key":"1081_CR12","first-page":"104","volume":"69","author":"M Honda","year":"2010","unstructured":"Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma. 2010;69:104\u20139.","journal-title":"J Trauma"},{"key":"1081_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF03256432","volume":"16","author":"L Schiff","year":"2012","unstructured":"Schiff L, Hadker N, Weiser S, Rausch C. A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury. Mol Diagn Ther. 2012;16:79\u201392.","journal-title":"Mol Diagn Ther"},{"key":"1081_CR14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2005.09.007","volume":"240","author":"K Nyl\u00e9n","year":"2006","unstructured":"Nyl\u00e9n K, \u00d6st M, Csajbok LZ, Nilsson I, Blennow K, Nellg\u00e5rd B, et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci. 2006;240:85\u201391.","journal-title":"J Neurol Sci"},{"key":"1081_CR15","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1089\/neu.2011.2127","volume":"29","author":"E Czeiter","year":"2012","unstructured":"Czeiter E, Mondello S, Kovacs N, Sandor J, Gabrielli A, Schmid K, et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J Neurotrauma. 2012;29:1770\u20138.","journal-title":"J Neurotrauma"},{"key":"1081_CR16","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/cc10286","volume":"15","author":"S Mondello","year":"2011","unstructured":"Mondello S, Papa L, Buki A, Bullock MR, Czeiter E, Tortella FC, et al. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit Care. 2011;15:R156.","journal-title":"Crit Care"},{"key":"1081_CR17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/neu.2014.3635","volume":"32","author":"PJ McMahon","year":"2015","unstructured":"McMahon PJ, Panczykowski DM, Yue JK, Puccio AM, Inoue T, Sorani MD, et al. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. J Neurotraum. 2015;32:527\u201333.","journal-title":"J Neurotraum"},{"key":"1081_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/neu.2013.3040","volume":"31","author":"R Diaz-Arrastia","year":"2014","unstructured":"Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma. 2014;31:19\u201325.","journal-title":"J Neurotrauma"},{"key":"1081_CR19","first-page":"S14","volume":"75","author":"LF Marshall","year":"1991","unstructured":"Marshall LF, Marshall SB, Klauber MR, Clark MB, Eisenberg HM, Jane JA, et al. A new classification of head injury based on computerized tomography. Special Supplements. 1991;75:S14\u201320.","journal-title":"Special Supplements"},{"key":"1081_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1474-4422(10)70300-8","volume":"10","author":"GL Clifton","year":"2011","unstructured":"Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011;10:131\u20139.","journal-title":"Lancet Neurol"},{"key":"1081_CR21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/neu.1998.15.573","volume":"15","author":"JT Wilson","year":"1998","unstructured":"Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573\u201385.","journal-title":"J Neurotrauma"},{"key":"1081_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.93.06030325","volume":"6","author":"JH Ware","year":"1993","unstructured":"Ware JH. Analysis of longitudinal data: choosing and interpreting regression models. Eur Respir J. 1993;6:325\u20137.","journal-title":"Eur Respir J"},{"key":"1081_CR23","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(10)70065-X","volume":"9","author":"HF Lingsma","year":"2010","unstructured":"Lingsma HF, Roozenbeek B, Steyerberg EW, Murray GD, Maas AI. Early prognosis in traumatic brain injury: from prophecies to predictions. Lancet Neurol. 2010;9:543\u201354.","journal-title":"Lancet Neurol"},{"key":"1081_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nurt.2009.10.022","volume":"7","author":"AI Maas","year":"2010","unstructured":"Maas AI, Roozenbeek B, Manley GT. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics. 2010;7:115\u201326.","journal-title":"Neurotherapeutics"},{"key":"1081_CR25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/neu.2012.2548","volume":"30","author":"J Lei","year":"2013","unstructured":"Lei J, Gao G, Jiang J. Acute traumatic brain injury: is current management evidence based? An empirical analysis of systematic reviews. J Neurotrauma. 2013;30:529\u201337.","journal-title":"J Neurotrauma"},{"key":"1081_CR26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.injury.2009.01.002","volume":"40","author":"AD Nichol","year":"2009","unstructured":"Nichol AD, Cooper DJ, POLAR Study Investigators on behalf of the ANZICS-Clinical Trials Group, EPO Study Investigators on behalf of the ANZICS-Clinical Trials. Can we improve neurological outcomes in severe traumatic brain injury? Something old (early prophylactic hypothermia) and something new (erythropoietin). Injury. 2009;40:471\u20138.","journal-title":"Injury"},{"key":"1081_CR27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/neu.2008.0586","volume":"25","author":"KE Saatman","year":"2008","unstructured":"Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT, et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma. 2008;25:719\u201338.","journal-title":"J Neurotrauma"},{"key":"1081_CR28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/clinchem\/45.1.138","volume":"45","author":"U Missler","year":"1999","unstructured":"Missler U, Wiesmann M, Wittmann G, Magerkurth O, Hagenstr\u00f6m H. Measurement of glial fibrillary acidic protein in human blood: Analytical method and preliminary clinical results. Clin Chem. 1999;45:138\u201341.","journal-title":"Clin Chem"},{"key":"1081_CR29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2353\/ajpath.2006.050798","volume":"168","author":"PE Mouser","year":"2006","unstructured":"Mouser PE, Head E, Ha KH, Rohn TT. Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am J Pathol. 2006;168:936\u201346.","journal-title":"Am J Pathol"},{"key":"1081_CR30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000172632","volume":"27","author":"F Dvorak","year":"2009","unstructured":"Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis. 2009;27:37\u201341.","journal-title":"Cerebrovasc Dis"},{"key":"1081_CR31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1212\/01.WNL.0000120550.00643.DC","volume":"62","author":"PE Vos","year":"2004","unstructured":"Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62:1303\u201310.","journal-title":"Neurology"},{"key":"1081_CR32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrneurol.2012.21","volume":"8","author":"HA Choi","year":"2012","unstructured":"Choi HA, Badjatia N, Mayer SA. Hypothermia for acute brain injury\u2014mechanisms and practical aspects. Nat Rev Neurol. 2012;8:214\u201322.","journal-title":"Nat Rev Neurol"},{"key":"1081_CR33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.0000079019.02601.90","volume":"108","author":"JP Nolan","year":"2003","unstructured":"Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW, Kloeck WG, Billi J, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation. 2003;108:118\u201321.","journal-title":"Circulation"},{"key":"1081_CR34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361:1349\u201358.","journal-title":"N Engl J Med"},{"key":"1081_CR35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3171\/2012.6.JNS111690","volume":"117","author":"GL Clifton","year":"2012","unstructured":"Clifton GL, Coffey CS, Fourwinds S, Zygun D, Valadka A, Smith Jr KR, et al. Early induction of hypothermia for evacuated intracranial hematomas: a post hoc analysis of two clinical trials. J Neurosurg. 2012;117:714\u201320.","journal-title":"J Neurosurg"},{"key":"1081_CR36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S1481803500012471","volume":"12","author":"JL Fox","year":"2010","unstructured":"Fox JL, Vu EN, Doyle-Waters M, Brubacher JR, Abu-Laban R, Hu Z. Prophylactic hypothermia for traumatic brain injury: a quantitative systematic review. CJEM. 2010;12:355\u201364.","journal-title":"CJEM"},{"key":"1081_CR37","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/cc13835","volume":"18","author":"S Crossley","year":"2014","unstructured":"Crossley S, Reid J, McLatchie R, Hayton J, Clark C, MacDougall M, et al. A systematic review of therapeutic hypothermia for adult patients following traumatic brain injury. Crit Care. 2014;18:R75.","journal-title":"Crit Care"},{"key":"1081_CR38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3171\/2012.10.JNS12725","volume":"118","author":"S Yokobori","year":"2013","unstructured":"Yokobori S, Gajavelli S, Mondello S, Mo-Seaney J, Bramlett HM, Dietrich WD, et al. Neuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma decompression model. J Neurosurg. 2013;118:370\u201380.","journal-title":"J Neurosurg"},{"key":"1081_CR39","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1089\/neu.2008.0802","volume":"26","author":"G Lotocki","year":"2009","unstructured":"Lotocki G, de Rivero Vaccari JP, Perez ER, Sanchez-Molano J, Furones-Alonso O, Bramlett HM, et al. Alterations in blood\u2013brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma. 2009;26:1123\u201334.","journal-title":"J Neurotrauma"},{"key":"1081_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cct.2014.11.008","volume":"40","author":"J Lei","year":"2015","unstructured":"Lei J, Gao G, Mao Q, Feng J, Wang L, You W, et al. Rationale, methodology, and implementation of a nationwide multicenter randomized controlled trial of long-term mild hypothermia for severe traumatic brain injury (the LTH-1 trial). Contemp Clin Trials. 2015;40:9\u201314.","journal-title":"Contemp Clin Trials"},{"key":"1081_CR41","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0140-6736(03)15083-0","volume":"362","author":"F Shann","year":"2003","unstructured":"Shann F. Hypothermia for traumatic brain injury: how soon, how cold, and how long? Lancet. 2003;362:1950\u20131.","journal-title":"Lancet"},{"key":"1081_CR42","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/neu.2004.21.1553","volume":"21","author":"LE Pelinka","year":"2004","unstructured":"Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma. 2004;21:1553\u201361.","journal-title":"J Neurotrauma"},{"key":"1081_CR43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.annemergmed.2011.08.021","volume":"59","author":"L Papa","year":"2012","unstructured":"Papa L, Lewis LM, Falk JL, Zhang Z, Silvestri S, Giordano P, et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med. 2012;59:471\u201383.","journal-title":"Ann Emerg Med"},{"key":"1081_CR44","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/neu.2015.3873","volume":"32","author":"XJ Huang","year":"2015","unstructured":"Huang XJ, Glushakova O, Mondello S, Van K, Hayes RL, Lyeth BG. Acute temporal profiles of serum levels of UCH-L1 and GFAP and relationships to neuronal and astroglial pathology following traumatic brain injury in rats. J Neurotrauma. 2015;32:1179\u201389.","journal-title":"J Neurotrauma"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1081-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-015-1081-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1081-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1081-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:42:09Z","timestamp":1692052929000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-015-1081-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1081"],"URL":"https:\/\/doi.org\/10.1186\/s13054-015-1081-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725846368.793539004","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"20 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"362"}}